Profil
Dr. Yuval Cabilly is a Co- Founder and General Partner at Israel Biotech Fund.
He is on the Board of Directors at Ayala Pharmaceuticals, Inc., Biond Biologics Ltd., Pharma Two B Ltd., Ramot at Tel Aviv University Ltd. and Tau Ventures Ltd. Dr. Cabilly was previously employed as a Board Member by Tamarix Pharma Ltd. He received his undergraduate degree from Tel-Aviv University and a doctorate degree from Tel-Aviv University.
Aktive Positionen von Yuval Cabilly
| Unternehmen | Position | Beginn |
|---|---|---|
| AYALA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 19.10.2023 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Gründer | 01.12.2014 |
Ramot at Tel Aviv University Ltd.
Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as technology transfer company | Direktor/Vorstandsmitglied | 01.09.2020 |
Pharma Two B Ltd.
Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Develops combination drugs for neurological disorders | Direktor/Vorstandsmitglied | 01.09.2020 |
Biond Biologics Ltd.
Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug discovery and development | Direktor/Vorstandsmitglied | 01.03.2021 |
Tau Ventures Ltd.
Tau Ventures Ltd. Investment ManagersFinance TAU Ventures invests in companies located in Israel. The firm focuses on sectors such as the technology sector. It provides financing for pre-seed and seed stage capital requirements with initial investment size ranging up to USD 1 million. It acts as a lead investor and makes follow-on investments. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Yuval Cabilly
| Unternehmen | Position | Ende |
|---|---|---|
Tamarix Pharma Ltd
Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Develops a novel small compounds for reducing excessive apoptosis | Direktor/Vorstandsmitglied | - |
Ausbildung von Yuval Cabilly
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Ramot at Tel Aviv University Ltd.
Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as technology transfer company | Commercial Services |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharma Two B Ltd.
Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Develops combination drugs for neurological disorders | Health Technology |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Biond Biologics Ltd.
Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug discovery and development | Health Technology |
Tau Ventures Ltd.
Tau Ventures Ltd. Investment ManagersFinance TAU Ventures invests in companies located in Israel. The firm focuses on sectors such as the technology sector. It provides financing for pre-seed and seed stage capital requirements with initial investment size ranging up to USD 1 million. It acts as a lead investor and makes follow-on investments. | Finance |
Tamarix Pharma Ltd
Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Develops a novel small compounds for reducing excessive apoptosis | Health Technology |
Ayala Pharmaceuticals, Inc.
Ayala Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops cancer therapeutics | Health Technology |
















